APOA1 and atherosclerosis: In apoE-/-Fas-/- B6 mice that develop accelerated atherosclerosis and autoimmunity, we used a dose of Apo-A1 mimetic peptide twice as much as previously used in apoE-/- B6 mice [23,35].